Jayne Chace

FSDC Plc engages in the provision of media and video content solutions. The company was founded by Jeffrey Steven Lenton and Michael John Brookes on March 16, 1999 and is headquartered in London, the United Kingdom.

Renephra Ltd. develops medical devices. Its is developing ground-breaking new approaches to dialysis treatment in end-stage renal disease by accessing the interstitial fluid in the skin. This new approach enables water and toxin removal in a non-invasive manner. The company was founded by Paul Brenchley and Sandip Mitra in 2009 and is headquartered in Manchester, the United Kingdom.

Bioxydyn Ltd. provides magnetic resonance imaging applications and services. Its services include imaging protocol and charter, on-site and remote training, quality management, and quantitative imaging biomarkers. The company was founded by Geoffrey James Martin Parker in 2009 and is headquartered in Manchester, the United Kingdom.

Arvia Technology Ltd. provides water treatment and conservation technology and solutions. It products the Arvia Organics Destruction Cell (ODC) is a water and wastewater treatment system designed to reduce recalcitrant Chemical Oxygen Demand (COD), remove colour and destroy micro-pollutants. It serves to the chemicals, food, beverage, nuclear, pharmaceuticals and utilities. The company was founded by Nigel Willis Brown and Edward Roberts in 2007 and is headquartered in Warrington, the United Kingdom.

Intelligent Fingerprinting Ltd. engages in the provision of non-invasive fingerprint-based diagnostic technology solutions. Its products include drug screening cartridges, DSR-plus reader, collection kit for laboratory analysis, and breath alcohol testing. The company was founded by David Andrew Russell and Sue M. Jickells in 2007 and is headquartered in Cambridge, the United Kingdom.

Syrinix Ltd. develops pipeline monitoring technology. Its products include TrunkMinder and TransientMinder. The firm serves infrastructure managers, resource managers in major water-consuming businesses, and industry regulators. The company was founded by Paul William Linford in 2004 and is headquartered in Norwich, the United Kingdom.

Javelin Ventures Ltd (Javelin Ventures) is a venture capital firm founded in 2001 by Valerie Jolliffe and Janis Anderson. The firm is headquartered in London, United Kingdom.

IntelliQ Ltd. provides forensic analysis solutions to the retail industry. It solutions include intuitive analytics, transaction visualization, omni channel analysis and gift-wrapped automated investigations. The company was founded in 1991 and is headquartered in London, the United Kingdom.

Beach Solutions Ltd. provides software solutions for the semiconductor industry. It offers commercial tools to manage addressable registers and electronic design automation. The firm also offers EASI Tools suite which enables the development teams to produce semiconductors and system designs. The company was founded in 1998 and is headquartered in Plymouth, UK.

Nesta Investment Management LLP. (NESTA Investments) subsidiary of Nesta formerly NESTA, is a venture capital firm founded in 1998. The firm is headquartered in London city United Kingdom.

Thomas Swan Holdings Ltd. is a British chemical company founded in 1926 that produces over 100 performance and specialty chemicals. The private company is based in Consett, UK and is an expert in the manufacture of chemicals using state-of-the-art processing and solids isolation equipment. The company's products include a thickening agent for latex compounds, chemical peptisers for rubber, and catalyst and performance chemicals. The company also offers custom manufacturing services on a contract or toll basis.

Boundary Capital Partners LLP (Boundary Capital) is a venture capital firm founded in 2009. The firm is headquartered in London.

Foresight Clearwater Fund, a joint venture between Clearwater Corporate Finance Ltd and Foresight Group LLP, invests in smaller companies located in the UK with revenues of £5 - £35 million and profitable. The fund targets companies operating across a wide variety of manufacturing and service sectors. It provides financing for buyouts and growth capital requirements with an investment size ranging up to £1 million in each transaction and requiring total investment size of less than £10 million.

APIS Assay Technologies Ltd. engages in clinical potential of systems biology in the diagnosis of treatment. The company is headquartered in Manchester, the United Kingdom.